Welcome Note

artonroy

Dear Colleagues,
It is our pleasure to invite you to participate in The 14th International Congress on Stem Cell Biology and Technology taking place on 29-31 August 2018 in Tehran, Iran.
Following the success of the previous events, this 14th Congress will also address areas of stem cell science from bench to market in an exciting and informative manner. With world renowned speakers secured to present ground breaking news, Royan 14th International Stem Cell Biology and Technology will be a congress to be remembered & definitely not to be missed.
We know how important advances in stem cell science are. As the leading professional society for stem cell research in Iran, we are committed to building a network with international leaders in the stem cell field as a way to promote and foster the exchange of information and research.
Participants will enjoy cutting‐edge lectures and very active discussions by the world’s top scientists, senior researchers and postgraduate students. Topics to be covered, among others will be:
1. Current and future trends on stem cell science in
  Pluripotent Stem Cells and Adult Stem Cells
  Stem Cells in Cardiovascular Research
  Stem Cells in Neuroscience
  Stem Cells in Internal Organs Research
  Stem Cells in Skin and Derivatives Research
  Stem Cells in Bone and Cartilage Research
   Stem Cells in Reproduction
   Stem Cells in Cancer Research
   Bioinformatics in Stem Cell Research
2. Stem Cells and Regenerative Medicine
Join the Congress and benefit from expanding your network. Meet new friends, greet old colleagues and discuss new insight gained.
We wish you a fruitful and enjoyable congress and looking forward to welcoming you to Tehran.

Sara Pahlavan, Ph.D.

Congress Chairman of 14th Congress on Stem Cell Biology and Technology
   Scientific Background
Sara Pahlavan is a member of Royan Cardiovascular Group. She studied Biology in her BSc and graduated in MSc of Physiology from Shiraz University. During her undergraduate studies, she got interested in physiology of cardiac cells, specifically excitation-contraction coupling. To pursue her interest, she moved to Germany and started her graduate studies in Professor Peter Lipp’s lab at Universitäts Klinikum des Saarlandes.
There, she learned state of the art technologies such as simultaneous “patch-clamp” and “Ca2+ imaging” to study excitation-contraction coupling in cardiomyocytes. Furthermore, she used transgenic mice to study pathophysiology of inherited cardiac diseases with respect to electrophysiology and/or Ca2+ machinery.
Toward the end of her PhD studies, she got interested in using patient-specific iPSC-derived cardiomyocytes to study cardiac disease in human cardiac cells and to test new drugs. To pursue this goal, she moved to United States and started her postdoctoral fellowship in Professor Martin Morad’ lab at Medical University of South Carolina.
There she could develop a new genetically-encoded Ca2+ probe to study Ca2+ induced Ca2+ release and Ca2+ sparks in cardiomyocytes of healthy and patient-specific iPSC-derived cardiomyocytes. She joined Royan Institute at 2015 and currently she works as an Assistant Professor in cardiovascular Group with particular interest in using patient-specific iPSC-derived cardiomyocytes as an in vitro model to study cardiovascular diseases and developing new drugs.